Register now and save 10% on Understanding Ketamine and Psychedelic Integration workshops this spring and fall! Use coupon code HEAL2021 at checkout.*
*Now through April 1 at midnight PST. Discount applies to workshops May-October 2021; does not apply to CE or CME.

Psychoanalytic Psychedelic Clinical Consultation Group, Fall 2021, Section 2 | Online

A 12-week clinical consultation group with Jeffrey Guss, MD starting September 23rd, 2021.

RegisterApply nowCourse FullCourse Full

Event details

Psychedelic Integration Clinical Consultation Group

Fall 2021  Section 2

Faculty

Jeffrey Guss, MD.

Dates/Time

Thursdays 12:00 - 1:30 PM Eastern Time (EDT through November 6th/EST starting November 7th)

9/23, 9/30, 10/7, 10/14, 10/21, 10/28, 11/4, 11/11, 11/18, 12/2, 12/9, 12/16

Location

Online

Cost

$1,200 for 12-sessions

Optional CE certificate for $65.

To obtain your certificate, the CE form must be filled out within 14 days of class completion.

This course is by application only, Please click here to apply.

A limited number of diversity scholarships are available, please complete this application, in addition to the course application.

Certificate Programs

This course can be taken in partial fulfillment of the requirements for the Postgraduate Certificate in Psychedelic Integration Therapy or Ketamine-assisted Psychotherapy.

Program Description

This 12-week, 90-minute group is designed to provide a creative and supportive environment for analytically oriented clinicians to discuss psychedelic integration work within the discourse of psychoanalysis. Each week, one member of the group will present clinical material; usually this will mean material from patients in treatment, but other subjects of presentation are welcome, such as material from a non-clinical setting or direct personal experience.

This group presumes basic familiarity with psychedelic integration therapy, as taught through Fluence, as well as a solid grounding in psychoanalytic/dynamic therapy. PPCG will contain elements of peer supervision, if appropriate, but will also invite the practice of analytic listening, exploration of reverie, discussion of transference and countertransference processes, fantasy and imagination as well as embodied affect. We are hoping that transference to psychedelic medicines, themselves, will be a frequent topic of discussion: in our patients, in ourselves and in our culture.

This group will meet weekly, and will keep the same members of the 12-week period. We will, together, strive to create a supportive, safe, creative and expressive environment with the same confidentiality parameters as a psychotherapy group. While we invite personal sharing, as usual, we ask that any clinician's underground work giving medicines be kept out of group discussion completely. The group is open to practicing clinicians of all persuasions, but will emphasize psychoanalytic and psychodynamic perspectives.

Learning Objectives

At the end of the program, participants will be better able to...

  1. Assess and reflect on the motivations for which patients seek Psychedelic Integration Therapy
  2. Assess and verbalize the complex motivations of patients to seek out and use psychedelics
  3. Rate the variety of subjective experiences and emotions patients report with psychedelics with nonjudgmental curiosity
  4. Describe and acknowledge therapist reactions to patients who are seeking psychedelic experiences
  5. Rate in equal esteem psychedelic experiences that are thoughtful and growth oriented and ones that are recreational, spontaneous, or dissociative
  6. Assess and articulate how psychedelics can amplify transference
  7. Assess and articulate how transferences to psychedelics can become fused with therapist transferences
  8. Prepare for shifts in language, meaning, and self-concept that may accompany experiences with psychedelics
  9. Explain openly (in appropriate settings) about emotional responses (countertransference) to patient reports as they relate to the therapist’s own relationship to psychedelic therapy
  10. Describe states of psychic disruption that suggest a need for more intensive treatment
  11. Describe extended support services for the patient, including family or community resources
  12. Plan the guidance and support of non-drug self-transformation efforts as part of Psychedelic Integration Therapy

Accreditation

Information on Continuing Education Credit for Health Professionals (CE)

At this time Fluence is not able to offer CE for NY-state Psychologists or NY-state Social Workers for this course

  • CE credits for psychologists are provided by the Spiritual Competency Academy (SCA) which is co-sponsoring this program. The Spiritual Competency Resource Center is approved by the American Psychological Association to sponsor continuing education for psychologists. The Spiritual Competency Resource Center maintains responsibility for this program and its content.
  • The California Board of Behavioral Sciences accepts CE credits for LCSW, LPCC, LEP, and LMFT license renewal for programs offered by approved sponsors of CE by the American Psychological Association.
  • LCSWs, MFTs, and other mental health professionals from states other than California need to check with their state licensing board as to whether or not they accept programs offered by approved sponsors of CE by the American Psychological Association.
  • SCA is approved by the California Board of Registered Nursing (BRN Provider CEP16887) for licensed nurses in California.
  • SCA is an approved CE provider for National Board Certified Health and Wellness Coaches (CEP Number 100196)
  • For questions about receiving your Certificate of Attendance, contact David Gumpel, David@fluence8.com. For questions about CE, visit www.spiritualcompetency.com or contact David Lukoff, PhD at CE@spiritualcompetency.com.